East Meets West in Innovative Technologies for the Treatment of Coronary Artery Disease

"Sahajanand Medical Technologies PVT.LTD (SMTPL) is the first stent manufacturing company outside the US to launch the Paclitaxel Eluting 'Infinnium Stent' - used in nearly 25 countries worldwide - and the Sirolimus Eluting 'Supralimus Stent'.

- SIMPLE 1 data, presented at Euro PCR 2003 with extended follow-up at TCT 2004, has impressed interventionalists worldwide.
- SIMPLE 2, a prospective multi-center trial, has completed enrollment in 8 centers. Watch for 6-month follow-up data at TCT 2005. Once again 'East meets West'".

Source : TCTMD e-letter - What's New the Week of July 5, 2005

To access the EuroPCR online news, click here.

Strategic solutions for Pharmaceutical, Biotechnology and Medical Device Companies:

"As a leading global provider of discovery and development services and products for pharmaceutical, biotechnology and medical device companies, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help clients maximize the return on their R&D investments. With proven discovery through post-market resources, the company also offers compound partnering opportunities. PPD has more than 7,100 professionals worldwide with offices in 28 countries."

Treatment of Coronary Artery Disease :
Heart Center Patient Programme: click here.
Source: Heart Center Online.

Aucun commentaire: